Patents by Inventor Cristina Rodriguez-Padilla

Cristina Rodriguez-Padilla has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • SYNTHETIC PEPTIDES INDUCING IMMUNOGENIC CELL DEATH
    Publication number: 20220000967
    Abstract: The disclosure relates to TSP-1-derived peptides capable of inducing immunogenic cell death, in particular immunogenic cancer cell death. It further relates to uses of such peptides, in particular to prepare a pharmaceutical composition to allow or improve the efficiency of a therapy of cancer in a subject in need thereof.
    Type: Application
    Filed: November 6, 2019
    Publication date: January 6, 2022
    Applicants: SORBONNE UNIVERSITE, CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE
    Inventors: Philippe KAROYAN, Ana Carolina MARTINEZ TORRES, Maria Cristina RODRIGUEZ PADILLA
  • Antiproliferative protein from Bacillus thuringiensis var. thuringiensis
    Patent number: 5977058
    Abstract: The present invention provides an isolated and purified protein derived from Bacillus thuringiensis subspecies thuringiensis, having a molecular weight of approximately 20 kDa of SDS-PAGE, said protein having the partial amino acid sequence shown in SEQ ID No. 1, and wherein said protein displays cytotoxic effects against tumor cells. Also provided is a method of treating a neoplastic cell comprising administering a therapeutically effective dose of the composition of the present invention to said cell, and a method of activating macrophages, comprising administering a therapeutically effective dose of the composition of the present invention to said macrophages.
    Type: Grant
    Filed: April 2, 1997
    Date of Patent: November 2, 1999
    Assignees: Research Development Foundation, Universidad Autonoma de Nievo Leon
    Inventors: Bharat B. Aggarwal, Cristina Rodriguez-Padilla
  • Antiproliferative protein from Bacillus thuringiensis var. thuringiensis
    Patent number: 5824636
    Abstract: The present invention provides an isolated and purified protein derived from Bacillus thuringiensis subspecies thuringiensis, having a molecular weight of approximately 20 kDa of SDS-PAGE, said protein having the partial amino acid sequence shown in SEQ ID No. 1, and wherein said protein displays cytotoxic effects against tumor cells. Also provided is a method of treating a neoplastic cell comprising administering a therapeutically effective dose of the composition of the present invention to said cell.
    Type: Grant
    Filed: November 4, 1996
    Date of Patent: October 20, 1998
    Assignees: Research Development Corporation, Universidad Autonoma de Nuevo Leon
    Inventors: Bharat B. Aggarwal, Cristina Rodriguez-Padilla